DUBLIN--(BUSINESS WIRE)--Dec 2, 2022--
The "miRNA Sequencing and Assay Market Size, Share & Trends Analysis Report by Product & Service, by Technology, by Workflow, by Application, by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global miRNA sequencing and assay market size is expected to reach USD 823.5 million by 2030. The market is expected to register a CAGR of 13.25% from 2022 to 2030 owing to the growing application areas of miRNA sequencing in the healthcare sector. For instance, various research studies stated that miRNAs can be efficiently used as biomarkers in the prognosis and diagnosis of cancer (cervical, ovarian, and breast), sepsis, cardiovascular diseases, and nervous system conditions. Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders. For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.
Prominent players such as PerkinElmer Inc.; Illumina, Inc.; and Qiagen offer innovative sequencing products for several clinical applications. Furthermore, these companies have entered into several strategic initiatives with research institutes to expand the sequencing application in research studies. For instance, in January 2022, BIORCHESTRA, a South Korean biopharmaceutical company, entered into a partnership agreement with SK Biopharmaceuticals to accelerate research and development into novel therapeutic compounds that target miRNAs.
Key market players are involved in the development of new tools, instruments, and kits with high specificity and reproducibility, which is fueling the market growth. For instance, in October 2019, TriLink BioTechnologies introduced two primer sets for its CleanTag kit. Thermo Fisher Scientific's sequencer platform can prepare small RNA libraries using these new Ion Torrent Convert barcode primer sets. Such launches are expected to boost market growth.
miRNA Sequencing And Assay Market Report Highlights
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Product & Service Business Analysis
Chapter 5 Technology Business Analysis
Chapter 6 Workflow Business Analysis
Chapter 7 Application Business Analysis
Chapter 8 End-use Business Analysis
Chapter 9 Regional Business Analysis
Chapter 10 Competitive Landscape
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/6j5k1b
View source version on businesswire.com:https://www.businesswire.com/news/home/20221202005147/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/02/2022 05:30 AM/DISC: 12/02/2022 05:32 AM
http://www.businesswire.com/news/home/20221202005147/en